Stem cell-derived 'mini-brains' reveal potential drug treatment for rare disorder

September 8, 2015, University of California - San Diego

Using "mini-brains" built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to "rescue" dysfunctional cells by suppressing a critical genetic alteration.

Their findings are published in the September 8 online issue of Molecular Psychiatry.

The is called MECP2 duplication syndrome. First described in 2005, it is caused by duplication of genetic material in a specific region of the X chromosome that encompasses MECP2 and adjacent genes. The disorder displays a wide variety of symptoms, among them low muscle tone, developmental delays, recurrent respiratory infections, speech abnormalities, seizures, autistic behaviors and potentially severe intellectual disability.

It is heritable, but can also occur randomly. MECP2 duplication syndrome occurs almost exclusively in males. A similar disorder known as Rett (RTT) Syndrome, which involves MECP2 gene deletions, primarily affects females. Current treatment is largely symptomatic, involving therapies, drugs and surgeries that address specific issues.

As in previous, ground-breaking research with Rett Syndrome patients, senior author Alysson Muotri, PhD, associate professor in the UC San Diego departments of Pediatrics and Cellular and Molecular Medicine, and colleagues took skin cells from MECP2 duplication patients, converted them into induced (iPSC), then programmed the to become neurons that recapitulate the disorder more robustly than existing mouse models.

Muotri said analyses of the iPSC-derived neurons revealed novel molecular and cellular phenotypes, including an over-synchronization of the neuronal networks. Interestingly, these phenotypes go in a direction opposite of what scientists had previously reported for Rett syndrome, suggesting that the correct gene dosage is important for homeostasis in human neurons. More importantly, said Muotri, the finding with human neurons helped direct the next stage, a drug screening, which uncovered a - a histone deacetylase inhibitor that reversed all the MECP2 alterations in the mutant neurons, with no harm to control neurons.

"This work is encouraging for several reasons," said Muotri. "First, this compound had never before been considered a therapeutic alternative for neurological disorders. Second, the speed in which we were able to do this. With mouse models, this work would likely have taken years and results would not necessarily be useful for humans."

Muotri said the findings further underscore the potential of stem cell-based models as an efficient method for screening potential drug libraries for the ability to rescue human neuronal phenotypes in a dish. He said his research team would be concluding its preclinical studies in preparation for moving into clinical trials as soon as possible.

Explore further: Multiple models reveal new genetic links in autism

Related Stories

Multiple models reveal new genetic links in autism

November 11, 2014
With the help of mouse models, induced pluripotent stem cells (iPSCs) and the "tooth fairy," researchers at the University of California, San Diego School of Medicine have implicated a new gene in idiopathic or non-syndromic ...

Mystery of Rett timing explained in MeCP2 binding

April 13, 2015
For decades, scientists and physicians have puzzled over the fact that infants with the postnatal neurodevelopmental disorder Rett syndrome show symptoms of the disorder from one to two years after birth.

Rett syndrome gene dysfunction redefined

October 3, 2013
Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found ...

New research implicates immune system in Rett syndrome

May 11, 2015
New research by investigators at the University of Massachusetts Medical School suggests the immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe neurological disorder affecting ...

Recommended for you

How do we lose memory? A STEP at a time, researchers say

March 23, 2018
In mice, rats, monkeys, and people, aging can take its toll on cognitive function. A new study by researchers at Yale and Université de Montréal reveal there is a common denominator to the decline in all of these species—an ...

Brain's tiniest blood vessels trigger spinal motor neurons to develop

March 23, 2018
A new study has revealed that the human brain's tiniest blood vessels can activate genes known to trigger spinal motor neurons, prompting the neurons to grow during early development. The findings could provide insights into ...

Being hungry shuts off perception of chronic pain

March 22, 2018
Pain can be valuable. Without it, we might let our hand linger on a hot stove, for example. But longer-lasting pain, such as the inflammatory pain that can arise after injury, can be debilitating and costly, preventing us ...

From signal propagation to consciousness: New findings point to a potential connection

March 22, 2018
Researchers at New York University have discovered a novel mechanism through which information can be effectively transmitted across many areas in the brain—a finding that offers a potentially new way of understanding how ...

Using simplicity for complexity—new research sheds light on the perception of motion

March 22, 2018
A team of biologists has deciphered how neurons used in the perception of motion form in the brain of a fly —a finding that illustrates how complex neuronal circuits are constructed from simple developmental rules.

Focus on early stage of illness may be key to treating ALS, study suggests

March 22, 2018
A new kind of genetically engineered mouse and an innovation in how to monitor those mice during research have shed new light on the early development of an inherited form of amyotrophic lateral sclerosis (ALS).


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.